Immunicum submits application to FDA for INTUVAX
Immunicum, a Swedish biopharmaceutical company developing therapeutic cancer immunotherapies, has submitted [...]
Immunicum, a Swedish biopharmaceutical company developing therapeutic cancer immunotherapies, has submitted [...]
Follow-up data from a phase I/II clinical trial with INTUVAX [...]